Cannabis stocks soar after Trump shares video promoting drug’s use for seniors Video posted on Truth Social touts CBD as a ‘gamechanger’ and promotes Medicaid coverage of CBD products The Guardian - US · Sep 29, 2025
Are Cannabis Stocks Ready for a Long-Term Rebound? Cannabis stocks are soaring today in light of some positive remarks from President Donald Trump. What implications could this have for the industry’s long-term prospects? Barchart · Sep 29, 2025
What's Going On With Tilray Stock Today? Tilray Brands, Inc. (NASDAQ:TLRY) shares gained ground on Thursday after the marijuana company’s medical division expanded its portfolio in Germany with three newly certified cannabis strains. Benzinga · Aug 28, 2025
Tilray’s Stock Price Is Growing Like a Weed. Here’s Why, and What Comes Next. With rescheduling on the table, here are two option trades to play the potential spike in TLRY stock. Barchart · Aug 26, 2025
What's Going On With Tilray Brands (TLRY) Stock? Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading higher Tuesday, with the stock up 39% over the past week. Here’s what investors need to know. Benzinga · Aug 26, 2025
Tilray Stock Continues To Rally After Hours: Here's Why Its Moving Pharmaceuticals and cannabis lifestyle company, Tilray Brands Inc. (NASDAQ:TLRY), rallied 20.87% on Monday and is now showing no signs of slowing down, with another 4.32% gain after hours, as broad-based tailwinds begin to align in the company’s favor. Benzinga · Aug 26, 2025
Jefferies Just Raised Its Tilray Stock Price Target 33%. Should You Buy TLRY Here? Tilray stock extends gains as Jefferies raises its price target on the cannabis firm to $2. But caution is warranted as TLRY shares are already up some 300% versus their year-to-date low. Barchart · Aug 25, 2025
Tilray Brands (TLRY) Stock Is Surging Monday: What's Going On? Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading sharply higher Monday morning, bolstered by a positive note from Jefferies and growing optimism around significant U.S. cannabis reform this year. Jefferies analyst Kaumil Gajrawala maintained a Buy rating on the stock while raising the price target from $1.50 to $2. Benzinga · Aug 25, 2025
Tilray's High Hopes: The Catalyst Driving Cannabis Stocks Tilray's stock rally is fueled by market anticipation of a U.S. cannabis rescheduling decision, a key catalyst for the entire cannabis sector's future. MarketBeat · Aug 21, 2025
Is Tilray Stock a Buy, Sell, or Hold for August 2025? With global ambitions expanding and potential cannabis reclassification, should investors brace for upside? Or prepare for another volatile season? Barchart · Aug 20, 2025
Dear Tilray Stock Fans, Mark Your Calendars for September 21 Tilray says it requested an extension to regain compliance with minimum listing requirements of the Nasdaq Exchange. Here’s why TLRY shares are still not worth owning at current levels. Barchart · Aug 15, 2025
Tilray Eyes Reverse Stock Split As Nasdaq Listing Compliance Pressure Mounts Tilray Brands, Inc. (NASDAQ:TLRY) shares slipped Thursday after the company said it is seeking more time from Nasdaq to restore compliance with the exchange’s continued listing rules tied to its per-share price. Benzinga · Aug 14, 2025
What's Going On With Tilray Stock Today? Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading higher on Tuesday. Benzinga · Aug 12, 2025
Tilray Surges 14% After Hours On Trump Cannabis Reclassification Tilray Brands Inc. (NASDAQ:TLRY) stock surged by 14.13%, to $1.05 during after-hours on Monday. This surge follows a report suggesting that President Donald Trump is contemplating reclassifying marijuana, a move that could significantly impact the industry. Benzinga · Aug 12, 2025
Benzinga · Jul 29, 2025 Following Mixed Q4 Results, Tilray's Turnaround Strategy Is Put To The Test Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading lower Tuesday morning after the global cannabis and consumer goods company reported fourth-quarter revenue that fell short of analyst expectations. Here’s what investors need to know.
Benzinga · Jul 28, 2025 Tilray Misses Q4 Revenue, Beats EPS Estimates, Shares Slide Tilray Brands Inc (NASDAQ:TLRY) reported fourth-quarter financial results for fiscal 2025 after the market close on Monday. Here’s a rundown of the report.
Benzinga · Jul 15, 2025 Palantir, The Trade Desk, Tilray, Sonnet Biotherapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today U.S. stocks traded mostly flat on Monday as investors reacted to President Donald Trump’s announcement of a 30% tariff on all imports from the EU and Mexico, effective August 1. Inflation worries ahead of Tuesday's CPI data also weighed on sentiment. By the close, the Dow rose 0.2% to 44,459.65,…
MarketBeat · Jul 14, 2025 Tilray Shares Blazing: What's Behind the 55% Rally This Month? Tilray's recent 55% rally may draw investor attention, but do the potential benefits outweigh the continued risks of this cannabis leader?
Benzinga · Jul 14, 2025 Tilray Brands Stock Is Climbing Monday: What's Driving The Action? Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading higher Monday morning, building on a recent rally fueled by heavy trading volume and company announcements. The cannabis giant’s stock has been a focal point for investors in recent sessions, driven by a combination of high short interest and positive industry news.
Benzinga · Jul 9, 2025 What's Going On With Tilray Brands Stock? Shares of Tilray Brands Inc (NASDAQ:TLRY) are surging higher Wednesday, extending a recent rally on heavy trading volume. Here’s what investors need to know.
Benzinga · Jul 8, 2025 Tilray (TLRY) Stock Surges On Heavy Volume: What Investors Should Know Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading sharply higher Tuesday afternoon, continuing a recent trend of investor interest across social media despite a lack of company-specific news for the session. Here’s what investors need to know.
Benzinga · Jul 3, 2025 What's Going On With Tilray Brands Stock Today? Tilray Brands Inc (NASDAQ:TLRY) stock is trending across social media Thursday, despite a lack of fresh company-specific news for the session. The cannabis and consumer brands company made several strategic moves in June that could be fueling the current interest.
Benzinga · Jul 3, 2025 How I'm Trading 2025's Biggest Winners And Losers I just wrapped up a deep dive into what I'm calling the "real report card" for 2025 so far…and the results might surprise you.
MarketBeat · Feb 5, 2025 Seeking Stability? These 3 Stocks Offer Strong Potential Consumer staples companies may offer some protection against volatility during times of tariff uncertainty; these stocks could be a defensive play.
Benzinga · Dec 5, 2024 Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.